カテゴリ： 世界, 医療/バイオ, QYResearch

高カリウム血症治療薬の世界市場2023年：パティロマー、シクロケイ酸ジルコニウムナトリウム

■ 英語タイトル：Global Drugs to Treat Hyperkalemia Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8744）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8744
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[高カリウム血症治療薬の世界市場2023年：パティロマー、シクロケイ酸ジルコニウムナトリウム]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は高カリウム血症治療薬のグローバル市場について調査・分析し、世界の高カリウム血症治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（パティロマー、シクロケイ酸ジルコニウムナトリウム）、用途別セグメント分析（病院薬局、小売店薬局）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Vifor Pharma、Astrazeneca、Sanofi、CMP Pharma、Belcher Pharmaceuticalsなどが含まれています。高カリウム血症治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、高カリウム血症治療薬市場規模を算出する際に考慮しました。

・高カリウム血症治療薬市場の概要
- 高カリウム血症治療薬の種類別セグメント
- 世界の高カリウム血症治療薬市場規模：タイプ別分析（パティロマー、シクロケイ酸ジルコニウムナトリウム）
- 高カリウム血症治療薬の用途別セグメント
- 世界の高カリウム血症治療薬市場規模：用途別分析（病院薬局、小売店薬局）
- 世界の高カリウム血症治療薬市場規模予測（2018年-2029年）

・高カリウム血症治療薬市場の成長トレンド
- 高カリウム血症治療薬の地域別市場規模（2018年-2029年）
- 高カリウム血症治療薬市場ダイナミクス
- 高カリウム血症治療薬の業界動向
- 高カリウム血症治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：パティロマー、シクロケイ酸ジルコニウムナトリウム
- 世界の高カリウム血症治療薬のタイプ別市場規模（2018年-2023年）
- 世界の高カリウム血症治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院薬局、小売店薬局
- 世界の高カリウム血症治療薬の用途別市場規模（2018年-2023年）
- 世界の高カリウム血症治療薬の用途別市場規模（2024年-2029年）

・高カリウム血症治療薬の地域別市場規模
- 北米の高カリウム血症治療薬市場規模（2018年-2029年）
- 米国の高カリウム血症治療薬市場規模（2018年-2029年）
- ヨーロッパの高カリウム血症治療薬市場規模（2018年-2029年）
- アジア太平洋の高カリウム血症治療薬市場規模（2018年-2029年）
- 中国の高カリウム血症治療薬市場規模（2018年-2029年）
- 日本の高カリウム血症治療薬市場規模（2018年-2029年）
- 韓国の高カリウム血症治療薬市場規模（2018年-2029年）
- インドの高カリウム血症治療薬市場規模（2018年-2029年）
- オーストラリアの高カリウム血症治療薬市場規模（2018年-2029年）
- 中南米の高カリウム血症治療薬市場規模（2018年-2029年）
- 中東・アフリカの高カリウム血症治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Vifor Pharma、Astrazeneca、Sanofi、CMP Pharma、Belcher Pharmaceuticals

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Drugs to Treat Hyperkalemia market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Drugs to Treat Hyperkalemia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Drugs to Treat Hyperkalemia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Drugs to Treat Hyperkalemia in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Drugs to Treat Hyperkalemia include Vifor Pharma, Astrazeneca, Sanofi, CMP Pharma and Belcher Pharmaceuticals, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs to Treat Hyperkalemia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs to Treat Hyperkalemia.
The Drugs to Treat Hyperkalemia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drugs to Treat Hyperkalemia market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs to Treat Hyperkalemia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Vifor Pharma
Astrazeneca
Sanofi
CMP Pharma
Belcher Pharmaceuticals
Segment by Type
Patiromer
Sodium Zirconium Cyclosilicate
Segment by Application
Hospital Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs to Treat Hyperkalemia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs to Treat Hyperkalemia Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Patiromer
1.2.3 Sodium Zirconium Cyclosilicate
1.3 Market by Application
1.3.1 Global Drugs to Treat Hyperkalemia Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs to Treat Hyperkalemia Market Perspective (2018-2029)
2.2 Drugs to Treat Hyperkalemia Growth Trends by Region
2.2.1 Global Drugs to Treat Hyperkalemia Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs to Treat Hyperkalemia Historic Market Size by Region (2018-2023)
2.2.3 Drugs to Treat Hyperkalemia Forecasted Market Size by Region (2024-2029)
2.3 Drugs to Treat Hyperkalemia Market Dynamics
2.3.1 Drugs to Treat Hyperkalemia Industry Trends
2.3.2 Drugs to Treat Hyperkalemia Market Drivers
2.3.3 Drugs to Treat Hyperkalemia Market Challenges
2.3.4 Drugs to Treat Hyperkalemia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs to Treat Hyperkalemia Players by Revenue
3.1.1 Global Top Drugs to Treat Hyperkalemia Players by Revenue (2018-2023)
3.1.2 Global Drugs to Treat Hyperkalemia Revenue Market Share by Players (2018-2023)
3.2 Global Drugs to Treat Hyperkalemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs to Treat Hyperkalemia Revenue
3.4 Global Drugs to Treat Hyperkalemia Market Concentration Ratio
3.4.1 Global Drugs to Treat Hyperkalemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs to Treat Hyperkalemia Revenue in 2022
3.5 Drugs to Treat Hyperkalemia Key Players Head office and Area Served
3.6 Key Players Drugs to Treat Hyperkalemia Product Solution and Service
3.7 Date of Enter into Drugs to Treat Hyperkalemia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs to Treat Hyperkalemia Breakdown Data by Type
4.1 Global Drugs to Treat Hyperkalemia Historic Market Size by Type (2018-2023)
4.2 Global Drugs to Treat Hyperkalemia Forecasted Market Size by Type (2024-2029)
5 Drugs to Treat Hyperkalemia Breakdown Data by Application
5.1 Global Drugs to Treat Hyperkalemia Historic Market Size by Application (2018-2023)
5.2 Global Drugs to Treat Hyperkalemia Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs to Treat Hyperkalemia Market Size (2018-2029)
6.2 North America Drugs to Treat Hyperkalemia Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drugs to Treat Hyperkalemia Market Size by Country (2018-2023)
6.4 North America Drugs to Treat Hyperkalemia Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs to Treat Hyperkalemia Market Size (2018-2029)
7.2 Europe Drugs to Treat Hyperkalemia Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drugs to Treat Hyperkalemia Market Size by Country (2018-2023)
7.4 Europe Drugs to Treat Hyperkalemia Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs to Treat Hyperkalemia Market Size (2018-2029)
8.2 Asia-Pacific Drugs to Treat Hyperkalemia Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drugs to Treat Hyperkalemia Market Size by Region (2018-2023)
8.4 Asia-Pacific Drugs to Treat Hyperkalemia Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs to Treat Hyperkalemia Market Size (2018-2029)
9.2 Latin America Drugs to Treat Hyperkalemia Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drugs to Treat Hyperkalemia Market Size by Country (2018-2023)
9.4 Latin America Drugs to Treat Hyperkalemia Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs to Treat Hyperkalemia Market Size (2018-2029)
10.2 Middle East & Africa Drugs to Treat Hyperkalemia Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drugs to Treat Hyperkalemia Market Size by Country (2018-2023)
10.4 Middle East & Africa Drugs to Treat Hyperkalemia Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vifor Pharma
11.1.1 Vifor Pharma Company Detail
11.1.2 Vifor Pharma Business Overview
11.1.3 Vifor Pharma Drugs to Treat Hyperkalemia Introduction
11.1.4 Vifor Pharma Revenue in Drugs to Treat Hyperkalemia Business (2018-2023)
11.1.5 Vifor Pharma Recent Development
11.2 Astrazeneca
11.2.1 Astrazeneca Company Detail
11.2.2 Astrazeneca Business Overview
11.2.3 Astrazeneca Drugs to Treat Hyperkalemia Introduction
11.2.4 Astrazeneca Revenue in Drugs to Treat Hyperkalemia Business (2018-2023)
11.2.5 Astrazeneca Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Drugs to Treat Hyperkalemia Introduction
11.3.4 Sanofi Revenue in Drugs to Treat Hyperkalemia Business (2018-2023)
11.3.5 Sanofi Recent Development
11.4 CMP Pharma
11.4.1 CMP Pharma Company Detail
11.4.2 CMP Pharma Business Overview
11.4.3 CMP Pharma Drugs to Treat Hyperkalemia Introduction
11.4.4 CMP Pharma Revenue in Drugs to Treat Hyperkalemia Business (2018-2023)
11.4.5 CMP Pharma Recent Development
11.5 Belcher Pharmaceuticals
11.5.1 Belcher Pharmaceuticals Company Detail
11.5.2 Belcher Pharmaceuticals Business Overview
11.5.3 Belcher Pharmaceuticals Drugs to Treat Hyperkalemia Introduction
11.5.4 Belcher Pharmaceuticals Revenue in Drugs to Treat Hyperkalemia Business (2018-2023)
11.5.5 Belcher Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Drugs to Treat Hyperkalemia Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Patiromer
Table 3. Key Players of Sodium Zirconium Cyclosilicate
Table 4. Global Drugs to Treat Hyperkalemia Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Drugs to Treat Hyperkalemia Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drugs to Treat Hyperkalemia Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drugs to Treat Hyperkalemia Market Share by Region (2018-2023)
Table 8. Global Drugs to Treat Hyperkalemia Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drugs to Treat Hyperkalemia Market Share by Region (2024-2029)
Table 10. Drugs to Treat Hyperkalemia Market Trends
Table 11. Drugs to Treat Hyperkalemia Market Drivers
Table 12. Drugs to Treat Hyperkalemia Market Challenges
Table 13. Drugs to Treat Hyperkalemia Market Restraints
Table 14. Global Drugs to Treat Hyperkalemia Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drugs to Treat Hyperkalemia Market Share by Players (2018-2023)
Table 16. Global Top Drugs to Treat Hyperkalemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Hyperkalemia as of 2022)
Table 17. Ranking of Global Top Drugs to Treat Hyperkalemia Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drugs to Treat Hyperkalemia Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drugs to Treat Hyperkalemia Product Solution and Service
Table 21. Date of Enter into Drugs to Treat Hyperkalemia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drugs to Treat Hyperkalemia Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drugs to Treat Hyperkalemia Revenue Market Share by Type (2018-2023)
Table 25. Global Drugs to Treat Hyperkalemia Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drugs to Treat Hyperkalemia Revenue Market Share by Type (2024-2029)
Table 27. Global Drugs to Treat Hyperkalemia Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drugs to Treat Hyperkalemia Revenue Market Share by Application (2018-2023)
Table 29. Global Drugs to Treat Hyperkalemia Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drugs to Treat Hyperkalemia Revenue Market Share by Application (2024-2029)
Table 31. North America Drugs to Treat Hyperkalemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Drugs to Treat Hyperkalemia Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Drugs to Treat Hyperkalemia Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Drugs to Treat Hyperkalemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Drugs to Treat Hyperkalemia Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Drugs to Treat Hyperkalemia Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Drugs to Treat Hyperkalemia Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Drugs to Treat Hyperkalemia Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Drugs to Treat Hyperkalemia Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Drugs to Treat Hyperkalemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Drugs to Treat Hyperkalemia Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Drugs to Treat Hyperkalemia Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Drugs to Treat Hyperkalemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Drugs to Treat Hyperkalemia Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Drugs to Treat Hyperkalemia Market Size by Country (2024-2029) & (US$ Million)
Table 46. Vifor Pharma Company Detail
Table 47. Vifor Pharma Business Overview
Table 48. Vifor Pharma Drugs to Treat Hyperkalemia Product
Table 49. Vifor Pharma Revenue in Drugs to Treat Hyperkalemia Business (2018-2023) & (US$ Million)
Table 50. Vifor Pharma Recent Development
Table 51. Astrazeneca Company Detail
Table 52. Astrazeneca Business Overview
Table 53. Astrazeneca Drugs to Treat Hyperkalemia Product
Table 54. Astrazeneca Revenue in Drugs to Treat Hyperkalemia Business (2018-2023) & (US$ Million)
Table 55. Astrazeneca Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Drugs to Treat Hyperkalemia Product
Table 59. Sanofi Revenue in Drugs to Treat Hyperkalemia Business (2018-2023) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. CMP Pharma Company Detail
Table 62. CMP Pharma Business Overview
Table 63. CMP Pharma Drugs to Treat Hyperkalemia Product
Table 64. CMP Pharma Revenue in Drugs to Treat Hyperkalemia Business (2018-2023) & (US$ Million)
Table 65. CMP Pharma Recent Development
Table 66. Belcher Pharmaceuticals Company Detail
Table 67. Belcher Pharmaceuticals Business Overview
Table 68. Belcher Pharmaceuticals Drugs to Treat Hyperkalemia Product
Table 69. Belcher Pharmaceuticals Revenue in Drugs to Treat Hyperkalemia Business (2018-2023) & (US$ Million)
Table 70. Belcher Pharmaceuticals Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs to Treat Hyperkalemia Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Drugs to Treat Hyperkalemia Market Share by Type: 2022 VS 2029
Figure 3. Patiromer Features
Figure 4. Sodium Zirconium Cyclosilicate Features
Figure 5. Global Drugs to Treat Hyperkalemia Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Drugs to Treat Hyperkalemia Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Drugs to Treat Hyperkalemia Report Years Considered
Figure 10. Global Drugs to Treat Hyperkalemia Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Drugs to Treat Hyperkalemia Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Drugs to Treat Hyperkalemia Market Share by Region: 2022 VS 2029
Figure 13. Global Drugs to Treat Hyperkalemia Market Share by Players in 2022
Figure 14. Global Top Drugs to Treat Hyperkalemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Hyperkalemia as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Drugs to Treat Hyperkalemia Revenue in 2022
Figure 16. North America Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Drugs to Treat Hyperkalemia Market Share by Country (2018-2029)
Figure 18. United States Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Drugs to Treat Hyperkalemia Market Share by Country (2018-2029)
Figure 22. Germany Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Drugs to Treat Hyperkalemia Market Share by Region (2018-2029)
Figure 30. China Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Drugs to Treat Hyperkalemia Market Share by Country (2018-2029)
Figure 38. Mexico Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Drugs to Treat Hyperkalemia Market Share by Country (2018-2029)
Figure 42. Turkey Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Drugs to Treat Hyperkalemia Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Vifor Pharma Revenue Growth Rate in Drugs to Treat Hyperkalemia Business (2018-2023)
Figure 45. Astrazeneca Revenue Growth Rate in Drugs to Treat Hyperkalemia Business (2018-2023)
Figure 46. Sanofi Revenue Growth Rate in Drugs to Treat Hyperkalemia Business (2018-2023)
Figure 47. CMP Pharma Revenue Growth Rate in Drugs to Treat Hyperkalemia Business (2018-2023)
Figure 48. Belcher Pharmaceuticals Revenue Growth Rate in Drugs to Treat Hyperkalemia Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 慢性腎臓病用治療薬のグローバル市場展望 2023年-2029年：カルシウム模倣薬、ビタミンD、ステロール、カリウム結合剤、カルシウム系リン酸塩結合剤
  • がん治療薬の世界市場2023年：化学療法薬品、分子標的治療薬品、免疫療法薬品、ホルモン療法薬品、その他
  • 新型コロナウイルス感染症小分子薬の世界市場インサイト・予測（～2028年）
  • アドレナリン受容体遮断薬の世界市場2023年：アルファブロッカー、ベータブロッカー、その他
  • 貧血治療薬の世界市場2023年：サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8744 )"高カリウム血症治療薬の世界市場2023年：パティロマー、シクロケイ酸ジルコニウムナトリウム" (英文：Global Drugs to Treat Hyperkalemia Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。